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GLUT4, a 12 transmembrane protein, plays a major role in insulin mediated glucose transport in
muscle and adipocytes. For glucose transport, the GLUT4 protein needs to be translocated to the
plasmamembrane from the intracellular pool and it is possible that certain compounds may be able
to enhance this process. In the present work, we have shown that gallic acid can increase GLUT4
translocation and glucose uptake activity in an Akt-independent but wortmannin-sensitive manner.
Further analysis suggested the role of atypical protein kinase Cf/k in gallic acid mediated GLUT4
translocation and glucose uptake.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Insulin stimulates glucose transport in target tissues (muscles
and adipocytes) by inducing the translocation of glucose trans-
porter 4 (GLUT4) to the plasma membrane [1]. GLUT4 protein re-
sides in the intracellular vesicles, and is predominantly localized
to the perinuclear compartment in the basal state [2]. Phosphory-
lation of insulin receptor by insulin binding activates phosphati-
dylinositol 3-kinase (PI3K), and induces the activation of
downstream signaling molecules like protein kinase B (PKB/Akt)
and atypical PKCs (aPKCs), leading to GLUT4 translocation and glu-
cose uptake [3–6]. Studies have shown that insulin stimulates glu-
cose uptake primarily by inducing the GLUT4 translocation to the
plasma membrane rather than increasing the intrinsic activity of
the transporter protein [7]. Lack of insulin or defects in insulin sig-
naling pathway lead to a concomitant rise in blood glucose level
and hence to diabetes [8]. Among the different types of diabetes,
type 2 diabetes is characterized by insulin resistance, a condition
in which normal insulin level is inadequate to produce desired re-
sponse in fat, muscle and liver cells [9–13]. Since insulin resistance
is the major abnormality in type 2 diabetes, there has been consid-
erable interest in identifying insulin sensitizing agents to counter-
act insulin resistance for the treatment of type 2 diabetes. Any
compound that induces the exocytosis and/or decreases the endo-
cytosis will result in increased GLUT4 expression on the plasma
membrane, and ultimately enhance glucose absorption.chemical Societies. Published by E
hnapillai).The study reported here is a bioassay directed identiﬁcation of
the active principle from seabuckthorn leaves (Hippophae rhamno-
ides L. Elaeagnaceae), that induces GLUT4 translocation and glu-
cose uptake in 3T3-L1 cells. Seabuckthorn is widely distributed in
the mountainous regions of Asia and Europe. Berries and other
parts are widely used as medicine in China and middle Asia [14].
This plant is an important resource of natural products with anti-
oxidant, anti-tumor, hepatoprotective and immuno-modulatory
properties [15,16]. There are several reports suggesting the thera-
peutic applications of seabuckthorn in treating various ailments
like cancer, gastrointestinal, cardiovascular, liver and skin diseases
[17]. In the present study, we have identiﬁed and functionally
characterized gallic acid (GA) as the active principle from seabuck-
thorn leaf extract that increases glucose uptake in 3T3-L1 adipo-
cytes. GA stimulates glucose uptake by inducing GLUT4
translocation in a wortmannin-sensitive but Akt-independent
manner. Further analysis suggests that GA induces glucose uptake
via atypical protein kinase Cf/k.
2. Materials and methods
2.1. Chemicals and reagents
Cell culture media and supplements were obtained from
Sigma (St. Louis, MO, USA). 3T3-L1 cells were obtained from
National Centre for Cell Sciences, Pune, Maharashtra, India. The
myc-GLUT4-GFP construct was kindly provided by Prof. Jeffrey
E. Pessin, (Stony Brook University, NY, USA). Primary antibodies
against myc epitope, phospho-PKCf/kThr410/403, phospho-AktSer473,lsevier B.V. All rights reserved.
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gated anti-mouse, anti-rabbit secondary antibodies were pur-
chased from Cell Signaling (Beverly, MA, USA). Akt inhibitor III
(Akti) was from Calbiochem (Los Angeles, CA, USA). Authentic
sample of GA was obtained from Nice Chemicals, India. 2-
Deoxy-D-(3H)-glucose was obtained from Amersham Life Sciences
(Buckinghamshire, UK). Organic solvents and other chemicals
used for extraction and puriﬁcation were of the highest analytical
grade.
2.2. Plant extraction and column puriﬁcation
The plant material was collected from Leh (Ladakh, Jammu and
Kashmir, India) and was identiﬁed as H. rhamnoides ssp. Turkesta-
nica by Dr. O.P. Chaurasia, Scientist, Field Research Laboratory
(FRL), Defense Research and Development Organization, Leh, India.
Dried seabuckthorn leaves (50 g) were extracted repeatedly with
methanol at room temperature. The solvent was removed in a ro-
tary evaporator at 50 C and the concentrate was analyzed. The
crude extract was concentrated and dissolved in DMSO (20 mg/
ml) for the assay. A portion of the crude extract was subjected to
acid hydrolysis and separation of individual components was car-
ried out by column chromatography and gel-permeation chroma-
tography. The progress of separation of compounds was
monitored by thin-layer chromatography (TLC), circular paper
chromatography and high-performance liquid chromatography
(HPLC, Shimadzu, CTO-104SUP). Conﬁrmatory chemical tests, opti-
cal spectroscopy (infra red, ultra violet), 1H and 13C nuclear mag-
netic resonance spectroscopy (Bruker ADVANCE DPX300 series),
and mass spectroscopy (JEOL JMS 600 and Shimazdu GC–MS
5050 series) were used for molecular characterization.
2.3. Cell culture and transfection of 3T3-L1 preadipocytes
3T3-L1 cells were cultured in Dulbecco’s Modiﬁed Eagle’s Med-
ium (DMEM) containing 10% fetal bovine serum, 1% penicillin, 1%
streptomycin and 0.1% amphotericin B. Cells were maintained
and passaged as preconﬂuent cultures at 37 C in a 5% CO2 humid-
iﬁed incubator. Preadipocytes were transfected with myc-GLUT4-
GFP construct by electroporation. For this purpose, 106–107 cells
were resuspended in 400 ll DMEM and subjected to a single pulse
at 250 mV with the plasmid construct. The transfected cells were
cultured in DMEM containing 600 lg/ml of G418 to select stable
clones. Each clone was subcultured and screened by ﬂuorescent
microscopy. A stable clone expressing GLUT4, with proper intracel-
lular localization was used for further studies. Differentiation of
3T3-L1 ﬁbroblasts was carried out following standard protocols
with slight modiﬁcations. Completely conﬂuent plates were incu-
bated in DMEM containing 10% FBS with 500 lM 3-isobutyl-1-
methylxanthine (IBMX), 250 nM dexamethasone and 100 nM insu-
lin. Two days after incubation, the medium was replaced with
DMEM containing 100 nM insulin. Fresh culture medium was
added after 2 days and then every other day till the cells attained
adipocyte morphology.
2.4. GLUT4 translocation assay
3T3-L1 cells stably transfected with myc-GLUT4-GFP chimera
were grown to 70% conﬂuency on cover slips. After serum starva-
tion for 2 h, cells were induced with insulin, different concentra-
tions of plant extract or GA for 30 min. Cells were then washed
twice with phosphate buffered saline (PBS), and ﬁxed with 2%
paraformaldehyde. These were incubated with anti-myc antibody
for 1 h at room temperature, washed, and counterstained with
alexa-conjugated rabbit anti-mouse secondary antibody for
30 min and membrane GLUT4 was visualized by ﬂuorescencemicroscopy. Cells treated with insulin and DMSO vehicle were
used as positive and negative control, respectively. The images
were obtained with a 40 objective (Olympus-X-71, Olympus
America Inc., USA) and the total surface ﬂuorescence of the second-
ary antibody was taken into consideration. Fluorescence intensity
was calculated by Image-Pro Plus software (version 5.1.2).
2.5. Glucose uptake assay
Differentiated cells were induced with various concentrations
of plant extract or GA for 30 min. Adipocytes were pretreated
either with 100 nM wortmannin for 10 min or with 1 lM Akti for
1 h followed by treatment with GA for 30 min. After induction,
cells were washed with Krebs–Ringer-Phosphate (KRP) buffer,
and glucose uptake was initiated by the addition of 0.5 ml KRP buf-
fer containing 10 lM 2-deoxy-D-glucose and 0.1 lCi 2-deoxy-D-
(3H)-glucose. After 5 min, glucose uptake was terminated by wash-
ing the cells with ice cold KRP buffer for three times. Cells were
lysed with 0.1% sodium dodecyl sulfate (SDS) and the radioactivity
retained by the cell lysate was measured by a liquid scintillation
counter (LS 6500, Beckman Coulter, Fullerton, CA, USA). Insulin
was used as a positive control and cells treated with DMSO were
used as a negative control for the uptake assay.
2.6. Western blot analysis
Adipocytes were serum starved for 2 h and induced with DMSO,
50 nM insulin or 10 lM GA for 30 min. Following induction, the
cells were washed twice with ice cold PBS and incubated in a lysis
buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-glycero-
phosphate, 1 mM Na3VO4, 1 lg/ml leupeptin) for 5 min. The ly-
sates were brieﬂy sonicated for 5 s and centrifuged at 14 000g
for 10 min. Total protein was estimated and equal amount of pro-
tein (50 lg) were subjected to 10%-SDS–PAGE and transferred to
PVDF membrane. The membrane was blocked and incubated with
desired primary antibody for 2 h, washed, and incubated with
HRP-conjugated secondary antibody for 1 h. After washing the
membrane, bands were detected by Phototope-HRP Western Blot
detection system (Cell Signaling).3. Results
3.1. Extraction, fractionation and puriﬁcation of the active constituent
from seabuckthorn leaves
Analysis of the concentrated crude extract (henceforth referred
to as SBL) revealed the presence of signiﬁcant amounts of pheno-
lics based upon positive ferric reactions. An attempt to isolate
the active principle by chromatographic technique was not suc-
cessful. Hence, to resolve this problem, hydrolysis of SBL was car-
ried out. Aqueous sulfuric acid (7%) for 1 h at 70 C was found to be
optimum for complete hydrolysis of SBL. The products of hydroly-
sis (henceforth referred to as SBL-H+) were exhaustively extracted
with ethyl acetate. Initial extracts were yellow in color (green fer-
ric reaction) while the later fractions were less colored (blue black
ferric reaction). The concentrate obtained from the extraction was
subjected to extensive adsorption chromatography followed by
gel-permeation chromatography. Three compounds A, B and C
were isolated. Compound C isolated from the extract was a white
amorphous powder, soluble in methanol and water. This com-
pound gave a prominent color reaction with ferric chloride (bluish
black color) and was soluble in alkali solution giving pink color.
Based on the results of 1H and 13C NMR spectroscopy, compound
C appeared to be a small molecule with prominent UV absorption
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C could be GA. The argument was supported by direct comparison
of UV, NMR and paper chromatography data with commercially
obtained GA. Compounds A and B were identiﬁed as quercetin
and isorhamnetin, respectively, which are known to inhibit glucose
uptake. Hence our subsequent studies were focused on GA using
commercially available GA.
3.2. Seabuckthorn leaf extract and GA induces GLUT4 translocation in
transfected 3T3-L1 preadipocytes
Insulin is known to mobilize GLUT4 from specialized compart-
ment to the plasma membrane. This process can be studied
in vitro by using 3T3-L1 ﬁbroblasts expressing tagged GLUT4
[18]. 3T3-L1 preadipocytes stably expressing myc-GLUT4-GFP chi-
mera were incubated with various concentrations of SBL, SBL-H+
and GA for 30 min. Treatment with 50 nM insulin was used as a po-
sitive control. The amount of GLUT4 on the membrane was mea-
sured as the intensity of GLUT4 ﬂuorescence after non-
permeabilized ﬁxation. Surface expression of GLUT4 increased
with increasing concentration of SBL (data not shown) and SBL-
H+. It was observed that the maximum concentration of SBL-H+
(5 lg/ml) resulted in 65% increase in the levels of GLUT4 on the
plasma membrane (Fig. 1A and B) compared to untreated control
cells. Similar to SBL-H+, treatment with GA also induced membrane
translocation of GLUT4 in a concentration dependent manner. A
maximum of 90% induction of GLUT4 surface expression was ob-
served with 10 lM GA. However, further increase in the GA con-
centration reduced the expression of GLUT4 on the plasma
membrane (Fig. 1C and D).Fig. 1. Effect of SBL-H+ and GA on GLUT4 translocation. 3T3-L1 preadipocytes were tran
indicated concentrations of SBL-H+ or insulin for 30 min. Cells were ﬁxed and surface m
Images show the membrane GLUT4 (surface) upon treatment with varying concentration
measure non-speciﬁc ﬂuorescence. (B and D) Graph showing the percentage increas
concentration of SBL-H+ and GA compared to the basal condition. Values are shown as t3.3. Increased glucose uptake activity by seabuckthorn leaf extract and
GA
To determine if induction of GLUT4 translocation by SBL, SBL-H+
or GA led to increased glucose uptake in differentiated 3T3-L1 cells,
glucose transport assay was utilized. Treatment with 100 lg/ml of
crude SBL extract resulted in 35% increase in glucose uptake com-
pared to untreated cells (Fig. 2A). Subsequent assays with the frac-
tionated SBL-H+ showed an increase in glucose uptake in a
concentration dependent manner. At a maximum concentration
of 5 lg/ml, SBL-H+ showed a 58% increase in glucose transport
(Fig. 2A). This increase in glucose uptake activity correlates with
the increase in GLUT4 translocation using same concentration of
SBL-H+ as shown in Fig. 1. Treatment with GA also induced glucose
uptake in a concentration dependent manner. Ten micromolars of
GA showed 90% increase in glucose uptake activity compared to
untreated cells (Fig. 2B). Further increase in GA concentration re-
duced the rate of glucose transport. Since 10 lM GA and 50 nM
insulin showed similar induction of glucose uptake, it was interest-
ing to determine if simultaneous treatment of GA and insulin could
cause a synergistic increase in glucose transport. Addition of GA
along with insulin neither increased nor inhibited the glucose up-
take activity in 3T3-L1 adipocytes (data not shown).
3.4. The involvement of insulin signaling proteins in the cellular
phosphorylation induced by GA
GLUT4 translocation and glucose uptake in muscle cells and adi-
pocytes is mediated by two major signaling pathways: AMPK-
mediated insulin independent pathway and PI3K dependent insu-sfected with myc-GLUT4-GFP chimera, serum starved for 2 h, and incubated with
yc-GLUT4-GFP was labeled with alexa by indirect immunoﬂuorescence. (A and C)
of SBL-H+ or GA as indicated. Cells treated with vehicle (0.1% DMSO) were used to
e in ﬂuorescence intensity of secondary antibody upon treatment with varying
he mean ± S.D. of three different focal planes of the same experiment.
Fig. 2. Effect of SBL, SBL-H+ and GA on glucose uptake. Glucose uptake activity was analyzed by measuring the uptake of radiolabelled 2-deoxy glucose in differentiated 3T3-
L1 cells. Cells were serum starved for 2 h and incubated with the indicated concentration of insulin, SBL or SBL-H+ for 30 min. Cells incubated with vehicle (0.1% DMSO) alone
were used to measure the basal rate of glucose uptake. Radiolabelled 2-deoxy glucose uptake was measured using liquid scintillation counter. Data shown are percentage
increase in glucose uptake compared to the basal condition. (A) Increase in glucose uptake upon treatment with SBL or SBL-H+ or (B) varying concentration of GA. Values are
shown as the mean ± S.D. of three different experiments carried out in duplicates.
Fig. 3. Effect of wortmannin or Akti on GA stimulated glucose uptake. 3T3-L1
adipocytes were serum starved for 2 h, and incubated with 10 lM GA in the
presence or absence of wortmannin or Akti for 30 min. Cells incubated with vehicle
(0.1% DMSO) were used to measure the basal rate of glucose uptake. Radiolabelled
2-deoxy glucose uptake was measured using liquid scintillation counter. Data
shown are percentage increase in glucose uptake compared to the basal condition.
Values are shown as the mean ± S.D. of three different experiments carried out in
duplicates.
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dent pathway in GA stimulated glucose uptake, differentiated cellsFig. 4. Effect of GA on protein phosphorylation. Differentiated adipocytes were treated w
SDS–PAGE. After transferring to PVDF membrane, Akt, AMPK and aPKCf/k phosphorylatio
well as phosphorylation (A), whereas GA stimulated aPKCf/k phosphorylation similar towere treated with 10 lMGA for 30 min and the phosphorylation of
AMPK was analyzed. GA did not affect the phosphorylation of
AMPK (Fig. 4A). Next, to investigate the role of PI3K in GA induced
GLUT4 translocation and glucose uptake, 3T3-L1 cells were treated
with wortmannin, an inhibitor of PI3K signaling pathway. GA med-
iated glucose uptake was abolished by wortmannin (Fig. 3), sug-
gesting that the stimulation of glucose uptake following GA
treatment was PI3K dependent. Furthermore, we analyzed the acti-
vation status of Akt, a key downstream effector of PI3K. GA did not
promote Akt phosphorylation at Ser473 (Fig. 4A), suggesting that
activation of Akt may not be involved in GA mediated glucose up-
take. Hoehn et al. have shown a non-linear relationship between
the levels of activated Akt and glucose uptake and it was surprising
to see that only 5% of the total activated Akt is sufﬁcient to achieve
maximum GLUT4 translocation [20]. To rule out the involvement
of activated Akt in the GA induced glucose uptake, we have treated
3T3-L1 adipocytes with Akt inhibitor. Adipocytes treated with Akt
inhibitor did not affect the GA stimulated glucose uptake (Fig. 3),
conﬁrming that the GA induced glucose uptake is Akt independent.
Taken together, our observations suggest that the stimulatory ef-
fect of GA on glucose uptake is mediated via PI3K signaling path-
way, and is independent of Akt or AMPK.
3.5. GA stimulates the activation of PKCf/k in differentiated 3T3-L1
adipocytes
Since GA showed a PI3K dependent increase in glucose uptake
without activating Akt, it is possible that one of the products of
PI3K; phosphatidylinositol 3,4,5-trisphosphate, can activate atypi-ith 50 nM insulin or 10 lM GA for 30 min. Equal amount of protein was resolved by
n was detected by western blot analysis. Treatment with GA did not stimulate Akt as
insulin (B).
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lyzed the phosphorylation status of PKCf/k. Treatment with 10 lM
GA resulted in 1.4-fold increase in aPKCf/k phosphorylation
(Fig. 4B), suggesting the involvement of PKCf/k in GA-mediated
GLUT4 translocation and glucose uptake.
4. Discussion
Seabuckthorn is a deciduous plant widely distributed in the
mountainous regions of China, Russia and India. It is a rich source
of carotenoids, tocopherols, sterols, ﬂavonoids, lipids, ascorbic acid,
and tannins. Several of these compounds are known to have vari-
ous medicinal properties [23]. Considering the fact that seabuck-
thorn leaves contain large amount of polyphenols, which are
known to stimulate glucose uptake activity, we ventured to iden-
tify the active constituent from this plant that induces glucose
transport activity [24–26].
In this study, a systematic analysis was performed in order to
identify compounds from seabuckthorn leaves with glucose uptake
enhancing activity. Crude SBL extract showed a signiﬁcant stimula-
tion of glucose transport compared to the basal level. In order to
isolate the active principle, we tried various approaches including
gel-permeation chromatography, but with limited success. This is
because the phytochemicals in seabuckthorn exist as glycosides
or conjugates. To overcome this problem, the crude extract was
subjected to acid hydrolysis and further extracted with ethyl ace-
tate. The hydrolyzed product (SBL-H+) was found to be a mixture
of three major compounds viz. quercetin, isorhamnetin and GA.
Even though polyphenolic compounds are reported to have
in vitro and in vivo antidiabetic activity, many of the ﬂavones like
apigenin, luteolin, kaempferol, myrcetin, quercetin, isorhamnetin,
ﬁsetin, genistein, silybin and epigallocatechin gallate (EGCG) were
shown to inhibit glucose uptake in mice and rat adipocytes [27–
29]. Among these, apigenin, luteolin, kaempferol, quercetin, and
ﬁsetin were found to inhibit insulin stimulated activation of Akt,
and suppress insulin dependent translocation of GLUT4 to the plas-
ma membrane [30,31]. Many of the glycoside varieties of ﬂavones
are also known to inhibit insulin stimulated glucose uptake. Previ-
ous studies from our laboratory have shown that kaempferitrin can
inhibit insulin stimulated glucose uptake by directly interfering
with glucose transport channel and also by inhibiting insulin med-
iated signal transduction [32,33]. Based on these data, we specu-
lated that quercetin and isorhamnetin might not have any
antidiabetic activity. Therefore we focused on GA as a potential
compound in the SBL-H+ possessing increased glucose uptake
activity in 3T3-L1 cells.
We observed that GA treatment stimulated GLUT4 translocation
and glucose transport in a concentration dependent manner with
maximum stimulation at 10 lM concentration. GA, a small pheno-
lic compound, is a major component in several plants. Seabuck-
thorn leaf is also reported to have large amounts of GA [34]. It
has been demonstrated that GA possesses anti-allergic, anti-
inﬂammatory, anti-mutagenic and anti-carcinogenic effects [35–
37]. Although some of the reported antidiabetic plants possess
GA as a major chemical compound [38,39], studies so far have
not demonstrated GA as a compound with antidiabetic or anti-
hyperglycemic properties. Here, we have clearly shown the
antidiabetic property of GA in an in vitro cell-based assay system
wherein GA was found to induce GLUT4 translocation with subse-
quent stimulation of glucose uptake. Increased GLUT4 expression
on the plasma membrane is important for the uptake of glucose
into the adipose and muscle tissues, and plays a key role in main-
taining normal blood glucose level.
To investigate the mechanism of stimulation of GLUT4 translo-
cation and glucose uptake by GA, we examined the effect of GAon cellular signaling pathways known to modulate these pro-
cesses. It has been shown that GLUT4 translocation and glucose
uptake are mediated by two major pathways; an insulin indepen-
dent AMPK pathway and an insulin mediated PI3K pathway. Re-
cently, Lee et al. have reported that berberine stimulates
glucose uptake in 3T3-L1 adipocytes and L6 myotubes in an
AMPK-dependent pathway [40]. To identify whether GA also in-
creases GLUT4 translocation in a similar manner, we determined
the level of phosphorylated AMPK in GA treated 3T3-L1 cells.
However, we did not see any AMPK activation (Fig. 4A), suggest-
ing that AMPK does not play a role in GA mediated glucose
uptake.
Activation of PI3K is a major event in the early phases of insu-
lin signaling cascade. Further, this insulin stimulated PI3K signal-
ing diverges into two pathways, an Akt dependent pathway and a
protein kinase C mediated pathway [41]. Even though Akt activa-
tion is important for insulin mediated glucose uptake, studies
have shown that insulin can increase glucose uptake in cells
expressing dominant negative mutant of Akt [42]. Furthermore,
it is reported that the ED50 for insulin stimulated GLUT4 translo-
cation in adipocytes is less than that of insulin stimulated Akt
activation [43]. It is known that insulin activates aPKCf/k as a
downstream effector of PI3K activation [44]. Our ﬁndings demon-
strate that GA induces glucose uptake in a PI3K dependent manner
and not through the activation of AMPK. This is conﬁrmed by the
inhibitory effect of wortmannin on GA induced glucose uptake.
Further, to identify the downstream activators of PI3K which are
involved in GA stimulated glucose uptake, we analyzed the phos-
phorylation status of Akt and aPKCf/k. Unlike insulin, GA did not
stimulate Akt phosphorylation in differentiated adipocytes. Also
Akt inhibitor did not inhibit GA mediated glucose uptake suggest-
ing the absence of Akt involvement in GA mediated glucose up-
take. However, GA treatment resulted in the activation of PKCf/k
similar to insulin.
The participation of PKCf in insulin stimulated glucose uptake
has been documented in muscles and adipocytes [45]. Phosphati-
dylinositol (3,4,5)-trisphosphate (PIP3), the product of insulin
mediated PI3K activation, recruits PDK-1 to the plasma mem-
brane by direct binding to its pleckstrin homology (PH) domain.
When translocated to the membrane, PDK-1 activates PKCf by
phosphorylating Thr410 [46]. In adipocytes, Cb1-TC10 pathway
is also activated in parallel to insulin signaling pathway, and
PKCf/k serves as a convergent downstream target for IRS-PI3K
and Cb1-TC10 pathway in 3T3-L1 adipocytes. Studies have shown
that TC10 activation leads to actin remodeling through PKCf and
is important for insulin stimulated GLUT4 translocation [47,48]. In
adipocytes, activated TC10 recruits PKCf/k to the plasma mem-
brane through Par6–Par3 complex. Also it has been shown that
PKCf interacts with protein kinase C substrate 80-KH and releases
the clamp action of Munc-18c to facilitate the docking of GLUT4
vesicle [49]. Our results suggest that GA stimulates GLUT4 trans-
location and glucose uptake in an aPKCf/k dependent manner.
Further studies need to be carried out to understand how GA in-
duced aPKCf/k activation mediates GLUT4 translocation and vesi-
cle sorting.
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